CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Raben David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +575,000 | 575,000 | ||
| 2026-07-09 | Borellini Flavia Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2026-07-09 | Iannone Robert Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2026-06-11 | CROWELL GAYLE A Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-11 | MCCOURT Thomas A Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-11 | Krognes Steve E. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-11 | Curnutte John T Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-11 | Huh Hoyoung Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-11 | Cline Darren S Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-04-17 | Kuo Minnie Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | ||
| 2026-04-17 | Kuo Minnie Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2026-04-17 | Kuo Minnie Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2026-04-17 | Kuo Minnie Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-04-17 | Kuo Minnie Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −55,200 | 0 | ||
| 2026-04-17 | Kuo Minnie Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +55,200 | 55,200 | ||
| 2026-04-17 | Cummings Keith Lamont Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −76,047 | 0 | ||
| 2026-04-17 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +76,047 | 76,047 | ||
| 2026-04-17 | Cummings Keith Lamont Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −18,198 | 0 | ||
| 2026-04-17 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +18,198 | 18,198 | ||
| 2026-04-17 | Cummings Keith Lamont Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −74,250 | 0 |
Page 1 of 8 · 160 trades